缺铁性贫血治疗市场规模和增长报告，2030年

缺铁性贫血治疗市场分析及规模

全球缺铁性贫血治疗市场正在经历显著增长，这得益于缺铁性贫血发病率的上升、新药的上市以及社会对女性健康（尤其是贫血）的关注。该市场的特点是，有大量参与者提供各种治疗方案，以满足该地区医疗保健提供者的不同需求。

Data Bridge Market Research 分析，全球缺铁性贫血治疗市场规模预计将从 2023 年的 48.6 亿美元增至 2031 年的 100.8 亿美元，在 2024 年至 2031 年的预测期内，复合年增长率为 10.0%。缺铁性贫血发病率的上升预计将推动市场扩张。

报告指标	细节
预测期	2024 至 2031 年
基准年	2023
历史性的一年	2022（可定制 2016-2021）
定量单位	收入（十亿美元）
涵盖的领域	治疗（肠外铁剂治疗和口服铁剂治疗）、治疗领域（妇产科、肾病、充血性心力衰竭 (CHF)、肿瘤科、炎症性肠病及其他）、人群（成人、老年人及儿童）、最终用户（医院、专科诊所、家庭护理环境及其他）、分销渠道（医院药房、药店和零售药房以及网上药房）
覆盖国家	墨西哥、加拿大、美国、英国、德国、意大利、法国、西班牙、比利时、瑞士、土耳其、俄罗斯、荷兰、欧洲其他地区、印度、中国、日本、澳大利亚、泰国、马来西亚、韩国、菲律宾、新加坡、印度尼西亚、亚太其他地区、阿根廷、巴西、南美洲其他地区、南非、埃及、沙特阿拉伯、阿联酋、以色列、中东和非洲其他地区
涵盖的市场参与者	Vifor Pharma Ltd.、DAIICHI SANKYO COMPANY, LIMITED、AFT Pharmaceuticals.、Sanofi、Pfizer Inc.、Fresenius Kabi AG、PHARMACOSMOS Therapeutics Inc、Thorne、Lupin、BLACKMORES、Shield Therapeutics plc、Aspen Pharmacare Australia Pty Ltd. Health Care 等。

市场定义

缺铁性贫血治疗是一种旨在补充铁储备和纠正缺铁引起的贫血的治疗方法。治疗的主要目标是恢复正常的铁水平和血红蛋白生成，从而改善疲劳、虚弱和呼吸急促等症状。治疗通常包括口服补铁，可以是硫酸亚铁、葡萄糖酸亚铁或柠檬酸铁，可以单独服用或与其他药物联合使用以增强吸收和疗效。在严重的情况下，可能需要静脉注射铁疗法，在某些情况下，可能需要输血来快速提高血红蛋白水平。

全球缺铁性贫血治疗市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：

驱动程序

缺铁性贫血发病率上升

贫血是指血液中血红蛋白浓度过低。贫血是影响世界所有经济阶层（包括低收入、中等收入和高收入国家）的健康问题。贫血会给健康带来严重不良后果，并对经济和社会发展产生更严重的影响。

贫血的病因多种多样，其中最常见的是缺铁。约有 50% 的贫血病例是由缺铁引起的，但该比例可能因各种因素而异。

贫血的其他原因包括其他微量营养素的缺乏（例如维生素 A、叶酸、核黄素和 B12）、慢性和急性感染（例如癌症、结核病、疟疾和艾滋病毒）以及影响血红蛋白合成、红细胞 (RBC) 生成或存活的获得性或遗传性疾病。

缺铁性贫血是全球最常见的贫血类型。在这种情况下，血液中缺乏足够的健康红细胞（RBC），而红细胞的功能是将氧气输送到身体的组织。缺铁性贫血是由于缺铁引起的。

由于身体缺乏适当的营养和各种炎症，导致铁的吸收不良，从而导致缺铁性贫血的患病率增加。

例如，

根据印度支出 (India Spend) 于 2016 年发布的一份报告，印度 20% 的产妇死亡是由贫血引起的，2016 年 10 月，贫血是 50% 产妇死亡的相关原因。贫血会导致婴儿出生体重过轻，并给他们带来终身的身体发育和智力发育问题风险。据统计，与更健康的同龄人相比，贫血儿童成年后的效率会降低 2.5%。
根据 2017 年全球营养报告，印度育龄妇女（15 至 49 岁）中超过一半（51%）患有贫血，而根据 2015-16 年第四次全国家庭健康调查 (NFHS-IV) 报告估计，印度育龄妇女中 53% 患有贫血

新药上市

创新推动进步，新药、领先产品和生物制品的出现往往意味着新的希望和更好的治疗选择，也意味着全世界人民的医疗保健水平将得到提升。有些产品是全新的创新产品，采用从未在临床实践中使用过的新方法，具有治愈全世界人民顽疾的潜在益处。各种药物和疗法都经过先进的研发和彻底的测试，以检查其功效。

例如，

2023年12月，据FDA发表的文章称，美国FDA批准了两种具有里程碑意义的治疗方法Casgevy和Lyfgenia，作为首个针对12岁以上镰状细胞病（SCD）患者的基于细胞的基因疗法。值得注意的是，Casgevy是FDA批准的首个使用新型基因组编辑技术的治疗方法，标志着基因治疗的重大进步
这些突破将推动全球缺铁性贫血治疗市场的发展，凸显创新治疗的潜力，并鼓励贫血相关疗法的进一步研究和开发
2023 年 9 月，根据葛兰素史克公司发表的一篇文章，葛兰素史克公司宣布 FDA 批准 Ojjaara (momelotinib) 用于治疗患有贫血的成人中度或高风险骨髓纤维化，包括原发性和继发性骨髓纤维化。Ojjaara 是一种每日一次口服的 JAK1/JAK2 和 ACVR1 抑制剂，是唯一获批用于治疗新诊断和既往接受过治疗的贫血骨髓纤维化患者的药物，可治疗贫血、全身症状和脾肿大。

机会

增加研发活动

数千年来，草药、真菌和植物一直被用于治疗贫血症。贫血症在世界范围内的患病率不断上升，这给世界带来了一个社会问题，导致需要在这一领域开展更严格的研究和开发。经过数十年的持续宣传和教育，利用缺铁性贫血作为治疗和发现工具的严格研究和开发已经非常丰富。

目前，除了个人研究外，私人诊所、营利和非营利组织资助的研究机构也在开展各种研究。这些研究包括针对慢性心脏病、依赖透析或不依赖透析的慢性肾病引起的缺铁性贫血的静脉注射疗法临床试验。

例如，

2022 年 3 月，根据美国国家心肺血液研究所发表的一篇文章，NHLBI 研究人员为再生障碍性贫血的治疗做出了贡献，再生障碍性贫血是一种罕见的疾病，骨髓无法产生足够的血细胞。他们开发了免疫抑制药物来治疗这种疾病。NHLBI 资助的研究继续探索贫血的原因，调查健康个体和贫血患者的红细胞生成情况。此外，NHLBI 和 NCI 于 2001 年启动了血液和骨髓移植临床试验网络，以推进移植疗法，有可能治愈某些类型的贫血
这些努力为全球缺铁性贫血治疗市场提供了机遇，通过促进包括基因疗法在内的治疗方法的创新，以及支持可能带来新的、有效的全球贫血治疗方法的临床试验

克制/挑战

炎症状态下缺铁性贫血的诊断局限性

缺铁性贫血是全球范围内的主要健康问题，是全球范围内日益严重的非致命性疾病之一，在普通临床实践中很常见。及时的预后和诊断至关重要，因为铁在所有器官系统的功能中都发挥着重要作用。尽管缺铁性贫血很普遍，但在患有炎症的患者中，缺铁性贫血通常被忽视，主要是因为临床准备指南中提供的症状和定义混杂在一起。

通常，最广为人知的缺铁风险人群是营养不良的人、需要大量铁摄入的人（如青少年或孕妇）以及患有慢性失血症（例如胃肠道出血或子宫肥大）的人。现在，越来越多的注意力转向与炎症相关的患者的铁状态，这些炎症容易导致缺铁。

其中最常见的是慢性肾病 (CKD)、慢性心力衰竭 (CHF) 和炎症性肠病 (IBD)。由于缺乏诊断方法或标记，对与炎症性疾病相关的患者缺铁的评估很少得到诊断。

例如，

2022 年 7 月，根据 PubMed Central 发表的一篇文章，缺铁性贫血 (IDA) 的诊断和治疗依赖于对缺铁的准确检测，而缺铁性贫血又因炎症、饮食和代谢变化等因素而变得复杂。目前的生物标志物，如血红蛋白 (Hb)、血清铁蛋白和转铁蛋白饱和度水平，都受到这些因素的影响，因此在某些情况下不可靠。例如，铁蛋白水平在炎症期间会升高，从而掩盖真正的铁水平。使用 sTfR-F 指数等多种标志物有望克服这些挑战，但仍然需要更强大的诊断工具
这种诊断的复杂性对全球缺铁性贫血治疗市场构成了重大挑战，需要开发更准确、更灵敏的诊断方法，以便可靠地识别和监测不同患者群体的铁状态，包括患有潜在炎症或镰状细胞性贫血等特定遗传疾病的患者
2018年，根据德国歌德大学阿加普莱西翁马库斯医院医学部和德国莱茵-美因克罗恩结肠炎跨学科中心在国际慢性病杂志上发表的一份报告，由于定义相互矛盾和患者分类标准不同，对患有炎症疾病人群的缺铁估计在不同研究中存在很大差异。他们发现，大约24–85%的CKD患者、50%的CHF患者和45%的IBD患者缺铁

最新动态

2023 年 6 月，GSK 获得了人用药品委员会 (CHMP) 的积极意见，建议批准 daprodustat 用于治疗接受长期维持性透析的成人慢性肾病 (CKD) 相关的症状性贫血。这项建议标志着为长期透析的 CKD 患者贫血管理提供新的治疗选择迈出了重要一步，解决了该人群中一个重要的未满足的医疗需求
2024年3月，Vafseo获得美国FDA批准，用于治疗透析依赖成年患者的慢性肾病引起的贫血。CSL Vifor很高兴其合作伙伴Akebia Therapeutics, Inc.宣布，美国食品药品监督管理局（FDA）已批准Vafseo（vadadustat）片剂用于治疗接受透析至少三个月的成年人因慢性肾病（CKD）引起的贫血。Vafseo是由Akebia开发的口服缺氧诱导因子脯氨酰羟化酶抑制剂（HIF-PHI）
2024 年 2 月，鲁宾公司在获得美国食品药品监督管理局 (US FDA) 批准后，推出了氰钴胺鼻喷雾剂，每喷 500 微克（每台设备喷一喷）
2023 年 12 月，诺华获得 FDA 批准 Fabhalta (iptacopan)，作为首个用于治疗阵发性睡眠性血红蛋白尿 (PNH) 成人患者的口服单药疗法，可在无需输血的情况下提供卓越的血红蛋白改善效果。宣布美国食品药品监督管理局 (FDA) 批准 Fabhalta (iptacopan) 作为首个用于治疗阵发性睡眠性血红蛋白尿 (PNH) 成人患者的口服单药疗法。 Fabhalta 是一种因子 B 抑制剂，在免疫系统的替代补体途径中发挥近端作用，全面控制血管内外的红细胞 (RBC) 破坏（血管内和血管外溶血 [IVH 和 EVH]）
2024年3月，加拿大卫生部批准Ferinject用于治疗成人和儿童缺铁性贫血以及成人心力衰竭患者缺铁症宣布，加拿大卫生部已批准Ferinject（羧麦芽糖铁）用于静脉（IV）治疗1岁及以上成人和儿童患者在口服铁制剂不耐受或无效时的缺铁性贫血，以及治疗成人心力衰竭患者缺铁症

全球缺铁性贫血治疗市场范围

全球缺铁性贫血治疗市场根据治疗、治疗领域、人口、最终用户和分销渠道分为五个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概况和市场洞察，以便做出战略决策，确定核心市场应用。

治疗

肠外铁疗法
口服铁剂疗法

根据治疗方法，市场分为肠外铁疗法和口服铁疗法。

治疗领域

妇产科
肾脏疾病
充血性心力衰竭 (CHF)
肿瘤学
炎症性肠病
其他的

根据治疗领域，市场细分为妇产科、肾脏疾病、充血性心力衰竭 (CHF)、肿瘤科、炎症性肠病和其他。

人口

成年人
老年
儿科

根据人口，市场分为成人、老年人和儿童。

最终用户

医院
专科诊所
家庭护理环境
其他的

根据最终用户，市场分为医院、专科诊所、家庭护理环境和其他。

分销渠道

医院药房
药店和零售药店
网上药店

根据分销渠道，市场分为医院药房、药店、零售药店、网上药店。

全球缺铁性贫血治疗市场区域分析/见解

对全球缺铁性贫血治疗市场进行了分析，并根据上述治疗、治疗领域、人群、最终用户和分销渠道提供了市场规模洞察和趋势。

本市场报告涵盖的国家包括墨西哥、加拿大、美国、英国、德国、意大利、法国、西班牙、比利时、瑞士、土耳其、俄罗斯、荷兰、欧洲其他地区、印度、中国、日本、澳大利亚、泰国、马来西亚、韩国、菲律宾、新加坡、印度尼西亚、亚太其他地区、阿根廷、巴西、南美洲其他地区、南非、埃及、沙特阿拉伯、阿联酋、以色列、中东和非洲其他地区。

北美因其先进的医疗基础设施而有望主导全球缺铁性贫血治疗市场。美国因该病发病率高、报销政策健全以及在研发方面投入大量资金而有望主导北美地区。英国因政府倾向于将社会医疗重点放在妇女健康（尤其是贫血）上而有望主导欧洲地区。印度有望主导亚太地区缺铁性贫血治疗市场。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。

竞争格局和全球缺铁性贫血治疗市场份额分析

全球缺铁性贫血治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对全球缺铁性贫血治疗市场的关注有关。

全球缺铁性贫血治疗市场的一些主要参与者包括 Vifor Pharma Ltd.、第一三共株式会社、AFT Pharmaceuticals.、赛诺菲、辉瑞公司、Fresenius Kabi AG、Pharmacosmos Therapeutics Inc、Thorne、Lupin、Blackmores、Shield Therapeutics plc、Aspen Pharmacare Australia Pty Ltd. Health Care 等。

SKU-29961

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 PREVALENCE OF ANEMIA IN CHILDREN OF AFRICA AND ASIA

TABLE 2 IRON DEFICIENCY ANEMIA THERAPEUTICS R&D ACTIVITIES

TABLE 3 CAUSES, PREVALENCE, AND CLINICAL CONSEQUENCES OF IRON DEFICIENCY IN INFLAMMATORY CONDITIONS

TABLE 4 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 5 GLOBAL PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 6 GLOBAL PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 7 GLOBAL ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 8 GLOBAL ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 9 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 10 GLOBAL OBSTETRICS AND GYNECOLOGY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 11 GLOBAL RENAL DISEASES IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 12 GLOBAL CONGESTIVE HEART FAILURE (CHF) IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 13 GLOBAL ONCOLOGY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 14 GLOBAL INFLAMMATORY BOWEL DISEASE IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 15 GLOBAL OTHERS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 16 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 17 GLOBAL ADULTS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 18 GLOBAL GERIATRIC IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 19 GLOBAL PEDIATRIC IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 20 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 21 GLOBAL HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 22 GLOBAL HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 23 GLOBAL SPECIALTY CLINICS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 24 GLOBAL HOME CARE SETTING IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 25 GLOBAL OTHERS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 26 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 27 GLOBAL HOSPITAL PHARMACY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 28 GLOBAL DRUG STORES AND RETAIL PHARMACIES IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 29 GLOBAL ONLINE PHARMACIES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 30 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 31 NORTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 32 NORTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 33 NORTH AMERICA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 34 NORTH AMERICA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 35 NORTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 36 NORTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 37 NORTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 38 NORTH AMERICA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 39 NORTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 40 MEXICO IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 41 MEXICO PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 42 MEXICO ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 43 MEXICO IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 44 MEXICO IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 45 MEXICO IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 46 MEXICO HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 47 MEXICO IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 48 CANADA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 49 CANADA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 50 CANADA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 51 CANADA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 52 CANADA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 53 CANADA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 54 CANADA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 55 CANADA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 56 U.S. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 57 U.S. PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 58 U.S. ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 59 U.S. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 60 U.S. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 61 U.S. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 62 U.S. HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 63 U.S. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 64 EUROPE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 65 EUROPE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 66 EUROPE PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 67 EUROPE ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 68 EUROPE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 69 EUROPE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 70 EUROPE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 71 EUROPE HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 72 EUROPE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 73 U.K. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 74 U.K. PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 75 U.K. ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 76 U.K. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 77 U.K. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 78 U.K. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 79 U.K. HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 80 U.K. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 81 GERMANY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 82 GERMANY PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 83 GERMANY ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 84 GERMANY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 85 GERMANY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 86 GERMANY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 87 GERMANY HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 88 GERMANY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 89 ITALY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 90 ITALY PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 91 ITALY ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 92 ITALY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 93 ITALY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 94 ITALY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 95 ITALY HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 96 ITALY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 97 FRANCE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 98 FRANCE PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 99 FRANCE ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 100 FRANCE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 101 FRANCE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 102 FRANCE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 103 FRANCE HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 104 FRANCE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 105 SPAIN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 106 SPAIN PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 107 SPAIN ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 108 SPAIN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 109 SPAIN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 110 SPAIN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 111 SPAIN HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 112 SPAIN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 113 BELGIUM IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 114 BELGIUM PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 115 BELGIUM ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 116 BELGIUM IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 117 BELGIUM IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 118 BELGIUM IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 119 BELGIUM HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 120 BELGIUM IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 121 SWITZERLAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 122 SWITZERLAND PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 123 SWITZERLAND ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 124 SWITZERLAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 125 SWITZERLAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 126 SWITZERLAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 127 SWITZERLAND HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 128 SWITZERLAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 129 TURKEY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 130 TURKEY PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 131 TURKEY ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 132 TURKEY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 133 TURKEY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 134 TURKEY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 135 TURKEY HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 136 TURKEY IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 137 RUSSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 138 RUSSIA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 139 RUSSIA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 140 RUSSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 141 RUSSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 142 RUSSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 143 RUSSIA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 144 RUSSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 145 NETHERLANDS IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 146 NETHERLANDS PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 147 NETHERLANDS ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 148 NETHERLANDS IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 149 NETHERLANDS IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 150 NETHERLANDS IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 151 NETHERLANDS HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 152 NETHERLANDS IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 153 EREST OF EUROPE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 154 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 155 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 156 ASIA-PACIFIC PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 157 ASIA-PACIFIC ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 158 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 159 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 160 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 161 ASIA-PACIFIC HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 162 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 163 INDIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 164 INDIA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 165 INDIA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 166 INDIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 167 INDIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 168 INDIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 169 INDIA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 170 INDIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 171 CHINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 172 CHINA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 173 CHINA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 174 CHINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 175 CHINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 176 CHINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 177 CHINA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 178 CHINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 179 JAPAN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 180 JAPAN PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 181 JAPAN ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 182 JAPAN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 183 JAPAN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 184 JAPAN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 185 JAPAN HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 186 JAPAN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 187 AUSTRALIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 188 AUSTRALIA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 189 AUSTRALIA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 190 AUSTRALIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 191 AUSTRALIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 192 AUSTRALIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 193 AUSTRALIA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 194 AUSTRALIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 195 THAILAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 196 THAILAND PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 197 THAILAND ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 198 THAILAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 199 THAILAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 200 THAILAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 201 THAILAND HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 202 THAILAND IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 203 MALAYSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 204 MALAYSIA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 205 MALAYSIA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 206 MALAYSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 207 MALAYSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 208 MALAYSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 209 MALAYSIA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 210 MALAYSIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 211 SOUTH KOREA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 212 SOUTH KOREA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 213 SOUTH KOREA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 214 SOUTH KOREA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 215 SOUTH KOREA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 216 SOUTH KOREA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 217 SOUTH KOREA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 218 SOUTH KOREA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 219 PHILIPPINES IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 220 PHILIPPINES PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 221 PHILIPPINES ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 222 PHILIPPINES IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 223 PHILIPPINES IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 224 PHILIPPINES IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 225 PHILIPPINES HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 226 PHILIPPINES IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 227 SINGAPORE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 228 SINGAPORE PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 229 SINGAPORE ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 230 SINGAPORE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 231 SINGAPORE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 232 SINGAPORE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 233 SINGAPORE HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 234 SINGAPORE IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 235 INDONESIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 236 INDONESIA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 237 INDONESIA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 238 INDONESIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 239 INDONESIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 240 INDONESIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 241 INDONESIA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 242 INDONESIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 243 REST OF ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 244 SOUTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 245 SOUTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 246 SOUTH AMERICA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 247 SOUTH AMERICA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 248 SOUTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 249 SOUTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 250 SOUTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 251 SOUTH AMERICA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 252 SOUTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 253 ARGENTINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 254 ARGENTINA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 255 ARGENTINA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 256 ARGENTINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 257 ARGENTINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 258 ARGENTINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 259 ARGENTINA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 260 ARGENTINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 261 BRAZIL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 262 BRAZIL PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 263 BRAZIL ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 264 BRAZIL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 265 BRAZIL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 266 BRAZIL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 267 BRAZIL HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 268 BRAZIL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 269 REST OF SOUTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 270 MIDDLE EAST AND AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 271 MIDDLE EAST AND AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 272 MIDDLE EAST AND AFRICA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 273 MIDDLE EAST AND AFRICA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 274 MIDDLE EAST AND AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 275 MIDDLE EAST AND AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 276 MIDDLE EAST AND AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 277 MIDDLE EAST AND AFRICA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 278 MIDDLE EAST AND AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 279 SOUTH AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 280 SOUTH AFRICA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 281 SOUTH AFRICA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 282 SOUTH AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 283 SOUTH AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 284 SOUTH AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 285 SOUTH AFRICA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 286 SOUTH AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 287 EGYPT IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 288 EGYPT PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 289 EGYPT ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 290 EGYPT IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 291 EGYPT IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 292 EGYPT IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 293 EGYPT HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 294 EGYPT IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 295 SAUDI ARABIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 296 SAUDI ARABIA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 297 SAUDI ARABIA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 298 SAUDI ARABIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 299 SAUDI ARABIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 300 SAUDI ARABIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 301 SAUDI ARABIA HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 302 SAUDI ARABIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 303 U.A.E. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 304 U.A.E. PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 305 U.A.E. ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 306 U.A.E. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 307 U.A.E. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 308 U.A.E. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 309 U.A.E. HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 310 U.A.E. IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 311 ISRAEL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

TABLE 312 ISRAEL PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 313 ISRAEL ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 314 ISRAEL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREA, 2022-2031 (USD MILLION)

TABLE 315 ISRAEL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2022-2031 (USD MILLION)

TABLE 316 ISRAEL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 317 ISRAEL HOSPITALS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 318 ISRAEL IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 319 REST OF MIDDLE EAST AND AFRICA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2022-2031 (USD MILLION)

图片列表

FIGURE 1 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: SEGMENTATION

FIGURE 2 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: END USER COVERAGE GRID

FIGURE 8 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: SEGMENTATION

FIGURE 10 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: STRATEGIC DECISIONS

FIGURE 11 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: SEGMENTATION TWO SEGMENTS COMPRISE

FIGURE 12 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: EXECUTIVE SUMMARY

FIGURE 13 RISING INCIDENCES OF IRON DEFICIENCY ANEMIA ARE DRIVING THE GROWTH OF THE GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET FROM 2024 TO 2031

FIGURE 14 THE THERAPY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET IN 2024 AND 2031

FIGURE 15 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 16 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR IRON-DEFICIENCY ANEMIA THERAPY MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 17 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGE OF GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET

FIGURE 18 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY THERAPY, 2023

FIGURE 19 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY THERAPY, 2024-2031 (USD MILLION)

FIGURE 20 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY THERAPY, CAGR (2024-2031)

FIGURE 21 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY THERAPY, LIFELINE CURVE

FIGURE 22 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY THERAPY AREA, 2023

FIGURE 23 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY THERAPY AREA, 2024-2031 (USD MILLION)

FIGURE 24 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY THERAPY AREA, CAGR (2024-2031)

FIGURE 25 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY THERAPY AREA, LIFELINE CURVE

FIGURE 26 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY POPULATION, 2023

FIGURE 27 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY POPULATION, 2024-2031 (USD MILLION)

FIGURE 28 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY POPULATION, CAGR (2024-2031)

FIGURE 29 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY POPULATION, LIFELINE CURVE

FIGURE 30 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY END USER, 2023

FIGURE 31 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 32 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY END USER, CAGR (2024-2031)

FIGURE 33 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 35 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 36 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 37 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: SNAPSHOT (2023)

FIGURE 39 GLOBAL IRON-DEFICIENCY ANEMIA THERAPY MARKET: COMPANY SHARE 2023 (%)

FIGURE 40 NORTH AMERICA IRON-DEFICIENCY ANEMIA THERAPY MARKET: COMPANY SHARE 2023 (%)

FIGURE 41 EUROPE IRON-DEFICIENCY ANEMIA THERAPY MARKET: COMPANY SHARE 2023 (%)

FIGURE 42 ASIA - PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET: COMPANY SHARE 2023 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

What is the current market value for the global iron-deficiency anemia therapy market?

The market value for the global iron-deficiency anemia therapy market in 2023 was USD 4.86 billion.

What is the growth rate of the global iron-deficiency anemia therapy market?

The global iron-deficiency anemia therapy market is expected to grow at a CAGR of 10.0% during the forecast period of 2024 to 2031.

Which are the major market drivers for the iron-deficiency anemia therapy market?

Rising incidences of iron deficiency anemia, introduction of novel drugs in the market, inclination towards social healthcare on women health specifically anemia are the major market drivers for the iron-deficiency anemia therapy market.

What are the major companies operating in this market?

Vifor Pharma Ltd. (Switzerland), DAIICHO SANKYO COMPANY LIMITED (Japan), AFT Pharmaceuticals. (New Zealand), Sanofi (France), Pfizer Inc. (U.S.) are the major companies operating in this market.

Which countries' data is covered in the global adhesion promoters market?

The countries in the global iron-deficiency anemia therapy market are Mexico, Canada, U.S., U.K., Germany, Italy, France, Spain, Belgium, Switzerland, Turkey, Russia, Netherlands, rest of Europe, India, China, Japan, Australia, Thailand, Malaysia, South Korea, Philippines, Singapore, Indonesia, rest of Asia-Pacific, Argentina, Brazil, rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, rest of Middle East and Africa.

Forecast Period	2024 –2031
Market Size (Base Year)	USD 4.86 Billion
Market Size (Forecast Year)	USD 10.08 Billion
CAGR	10.00 %
Major Markets Players	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

全球缺铁性贫血治疗市场 – 行业趋势和 2031 年预测

全球缺铁性贫血治疗市场 – 行业趋势和 2031 年预测

Global Iron Deficiency Anemia Therapy Market

CAGR : 10.00 %

缺铁性贫血治疗市场分析及规模

全球缺铁性贫血治疗市场动态

全球缺铁性贫血治疗市场范围

全球缺铁性贫血治疗市场区域分析/见解

竞争格局和全球缺铁性贫血治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

全球缺铁性贫血治疗市场 – 行业趋势和 2031 年预测

全球缺铁性贫血治疗市场 – 行业趋势和 2031 年预测

Global Iron Deficiency Anemia Therapy Market

CAGR : 10.00 %

缺铁性贫血治疗市场分析及规模

全球缺铁性贫血治疗市场动态

全球缺铁性贫血治疗市场范围

全球缺铁性贫血治疗市场区域分析/见解

竞争格局和全球缺铁性贫血治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面